2 active not recruiting, 2 completed, 1 unknown. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Pathologic Stage I Gastric Cancer AJCC v8: new trials by email Literature Review of Pathologic Stage I Gastric Cancer AJCC v8 trials Research Report on Pathologic Stage I Gastric Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System Robot-assisted surgery - Pathologic Stage I Gastric Cancer AJCC v8, Colorectal Cancer | Not applicable | Unknown | Cornerstone Robotics | 60 | 2024-01-22 | 2024-09-19 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | Completed | City of Hope Medical Center | 22 | 2020-08-11 | 2026-10-14 | |
| Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study Patient Monitoring System, Questionnaire Administration, Consultation - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | Not applicable | Completed | Thomas Jefferson University | 34 | 2020-04-15 | 2025-05-15 |
| Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery Best Practice, Quality-of-Life Assessment, Questionnaire Administration - Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8 | Active not recruiting | City of Hope Medical Center | 52 | 2019-01-08 | 2026-10-22 | |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer Fluorouracil, Intensity-Modulated Radiation Therapy, Ipilimumab - Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 32 | 2019-01-07 | 2026-10-06 |
Colorectal Neoplasms (3) · Carcinoma, Renal Cell (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1) · Urogenital Neoplasms (1) · Uterine Cervical Neoplasms (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms (2) · Adenocarcinoma (1) · Adnexal Diseases (1) · Carcinoma (1)
CTLA-4 Antigen (1) · Fluorouracil (1) · Ipilimumab (1) · Nivolumab (1) · Oxaliplatin (1) · Practice Guidelines as Topic (1) · Radiotherapy, Intensity-Modulated (1) · Referral and Consultation (1) · Remote Patient Monitoring (1) · Robotic Surgical Procedures (1) · Standard of Care (1) · dehydroftorafur (1)
City of Hope Medical Center (2) · Cornerstone Robotics (1) · M.D. Anderson Cancer Center (1) · Thomas Jefferson University (1)
United States (4) · China (1)
Kuang-Yi Wen, MD (1) · Laleh Melstrom (1) · Mariela Blum (1) · Xiujun Cai, MD (1) · Yanghee Woo (1)
P30CA033572 (1)